Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**
Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB2 receptor. These compounds selectively target CB2 versus CB1 rec...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/179068 |
| Acceso en línea: | https://hdl.handle.net/2445/179068 |
| Access Level: | acceso abierto |
| Palabra clave: | Receptors cel·lulars Proteïnes G Interacció cel·lular Cànnabis Cell receptors G Proteins Cell interaction Cannabis |
| Sumario: | Single chemical entities with potential to simultaneously interact with two binding sites are emerging strategies in medicinal chemistry. We have designed, synthesized and functionally characterized the first bitopic ligands for the CB2 receptor. These compounds selectively target CB2 versus CB1 receptors. Their binding mode was studied by molecular dynamic simulations and site-directed mutagenesis. |
|---|